Navigation Links
Neurocrine Biosciences Reports First Quarter 2008 Results
Date:4/30/2008

al trial.

Urocortin 2 for Congestive Heart Failure (CHF) Continues Preclinical Evaluation

Initiation of longer term (up to 72 hours in duration) Phase II clinical trials of urocortin 2 are awaiting additional preclinical data. The Company has identified a preclinical formulation that is currently undergoing safety and toxicology testing necessary for continuing the longer-term clinical studies. Neurocrine anticipates topline data from these preclinical studies late 2008 which will allow further Phase II clinical studies to progress.

Indiplon Update

The Company was scheduled to meet with the FDA for an end of review meeting following the December 12, 2007 approvable letter for indiplon capsules. The FDA requested a rescheduling of this meeting due to internal FDA scheduling conflicts. The end of review meeting has been rescheduled by the FDA to July 2008. The Company will provide an update of the results after the end of this review meeting.

Conference Call and Webcast Today at 5:00 PM Eastern Daylight Time

Neurocrine will hold a live conference call and webcast today at 5:00 p.m. Eastern Daylight Time (2:00 p.m. Pacific Daylight Time). Participants can access the live conference call by dialing 1-800-895-1715 (US) or 785-424-1059 (International) using the conference passcode 7NBIX1. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-800-753-9146 (US) or 402-220-2705 (International) using the passcode 7NBIX1. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical co
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
3. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
4. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
5. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
6. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
7. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
8. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
9. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
10. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
11. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... board of directors of Eli Lilly and Company (NYSE: ... the first quarter of 2010 of $0.49 a share ... is payable March 10, 2010 to shareholders of record ... 12, 2010. ,, Lilly, a leading innovation-driven corporation, is ... the latest research from its own worldwide laboratories and ...
(Date:12/14/2009)... Dec. 14 Zargis Medical Corp., a ... ) and a spin-off from Siemens Corporate Research ... it has begun selling its award-winning Zargis Cardioscan(TM) ... Cardioscan and its accompanying Bluetooth®-enabled electronic stethoscope were ... "2009 Innovation of the Year." Cardioscan ...
(Date:12/14/2009)... Gibraltar Associates, a leading public ... domestic communications and issues management, today announced ... PositiveID Corporation (Nasdaq: PSID ) to ... of record. Gibraltar Associates will conduct media ... the Company on its public relations programs. ...
Breaking Medicine Technology:Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation 2Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 1Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 2Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 3Bionovo Adds Dr Debu Tripathy to Their Medical Advisory Board 59431 1Bionovo Adds Dr Debu Tripathy to Their Medical Advisory Board 59431 2Bionovo Adds Dr Debu Tripathy to Their Medical Advisory Board 59431 3Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 1Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 2Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 3
(Date:12/14/2009)... bump in odds is small and shouldn,t worry most ... -- Older women who take antidepressants may have a ... death compared to women not on the medications, a ... different from clinical significance," stressed Dr. Jordan W. Smoller, ... and lead author of a report in the Dec. ...
(Date:12/14/2009)... 2 diabetes and obesity are linked to an increased ... that insulin glargine (a synthetic insulin preparation marketed under ... higher risk of certain cancers than other insulins or ... unable to control for important factors such as obesity ... the other hand, a large randomized trial designed to ...
(Date:12/14/2009)... functioning , , , MONDAY, Dec. 14 (HealthDay News) -- ... live longer than those who look older than their ... from research that involved 1,826 Danish twins, aged 70 ... and then had their faces photographed. Three groups of ... they perceived the participants to be. Twins were assessed ...
(Date:12/14/2009)... and the United Nations Foundation’s Nothing But Nets tipped off a ... HP--to send anti-malaria bed nets to refugees in 11 African countries. ... and runs through January 31, 2010. , ... ... National Basketball Association (NBA) and the United Nations Foundation’s Nothing But ...
(Date:12/14/2009)... Concetta F. Conkling of Moraga, CA, retired ... has been elected Chair of the Board of Trustees ... the nearly 90-year-old organization to which Helen Keller devoted ... York with offices in San Francisco, Dallas, ... is dedicated to expanding possibilities for people with vision ...
Breaking Medicine News(10 mins):Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Looking Younger Than Your Age May Mean Longer Life 2Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 2Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 3Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 4Health News:The American Foundation for the Blind Welcomes New Board Chair, Concetta F. Conkling 2
... Society of Cardiology (ESC) is calling for concerted action ... the World Heart Organisation (WHO). // ... full extent of the global burden of chronic diseases ... is anticipated that a global action to prevent chronic ...
... upon the foods we eat, the products we buy, the ... we spend time // . Evaluation of stimulus valence is ... uses it as a basic category for organizing information and ... to be immediate, unintentional and linked to behavioral responses. ...
... agreement in principle to enable the smooth transfer of ... is an encouraging sign for Indian bioscience. But slow ... India’s grandiose scheme to become the global hub of ... of becoming a major player. , ,Discussions in ...
... alarming rise in human cases of bird flu, causing increasing ... strong resolve in the scientific community to combat this impending ... flu has risen since October 5 when scientists from the ... reported finding similarities between the bird flu strain in Asia, ...
... dream come true for the scientists who been working hard ... expected to take an extra step ahead as it is ... as well as their offspring, are safe to eat., ... techniques, with Canadian Scientists having proved themselves following the success ...
... against, a London based leading drug company, GlaxoSmithKline for ... to the U.S. Food and Drug Administration two years ... review. This became evident last November when The FDA ... , ,The Public Citizen Group has registered a ...
Other Medicine News:Health News:Conditioning preferences in children 2Health News:Biologicals Transfer Proposal between US and Indian Biotechnology 2Health News:FDA Mislead On Asthma Drug By GlaxoSmithKline 2
... the new PRONEB® ULTRA compressor. This high ... while delivering more medication to the patient's ... PLUS® or PARI LC STAR® Reusable Nebulizer, ... for inhalation and retention into the lungs. ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
... TREK™ Compact Compressor is for active patients ... anywhere and everywhere. The compressor is small ... source optionsworldwide AC compatibility (100 to 240V), ... patients the freedom to take aerosol treatments ...
... ,Allied Healthcares Timeter® PCS 414 portable air compressor ... that you may wonder if its running. Youll ... a durable, mar-resistant steel case thats easy to ... 26.5 pounds. The PCS 414 has been engineered ...
Medicine Products: